These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26529122)

  • 1. The Combination of Anti-CTLA-4 and PD1-/- Mice Unmasks the Potential of Isoniazid and Nevirapine To Cause Liver Injury.
    Mak A; Uetrecht J
    Chem Res Toxicol; 2015 Dec; 28(12):2287-91. PubMed ID: 26529122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of CD8 T Cells in Amodiaquine-Induced Liver Injury in PD1-/- Mice Cotreated with Anti-CTLA-4.
    Mak A; Uetrecht J
    Chem Res Toxicol; 2015 Aug; 28(8):1567-73. PubMed ID: 26154582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editor's Highlight: An Impaired Immune Tolerance Animal Model Distinguishes the Potential of Troglitazone/Pioglitazone and Tolcapone/Entacapone to Cause IDILI.
    Mak A; Kato R; Weston K; Hayes A; Uetrecht J
    Toxicol Sci; 2018 Feb; 161(2):412-420. PubMed ID: 29087505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of immunization and checkpoint inhibition on amodiaquine-induced liver injury.
    Mak A; Johnston A; Uetrecht J
    J Immunotoxicol; 2017 Dec; 14(1):89-94. PubMed ID: 28279082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of an animal model to test whether non-alcoholic fatty liver disease increases the risk of idiosyncratic drug-induced liver injury.
    Mak A; Cho T; Uetrecht J
    J Immunotoxicol; 2018 Dec; 15(1):90-95. PubMed ID: 29733743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of PD-1(-/-) mice with amodiaquine and anti-CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients.
    Metushi IG; Hayes MA; Uetrecht J
    Hepatology; 2015 Apr; 61(4):1332-42. PubMed ID: 25283142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset.
    Metushi IG; Cai P; Dervovic D; Liu F; Lobach A; Nakagawa T; Uetrecht J
    J Immunotoxicol; 2015; 12(3):247-60. PubMed ID: 25046026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Immune Modulators on Amodiaquine-Induced Liver Injury.
    Mak A; Cho TE; Uetrecht J
    Chem Res Toxicol; 2018 Aug; 31(8):739-744. PubMed ID: 29938495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver Injury Caused by Green Tea Extract in PD-1
    Cho T; Wang X; Yeung K; Cao Y; Uetrecht J
    Chem Res Toxicol; 2021 Mar; 34(3):849-856. PubMed ID: 33617238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of CCL2/CCR2 macrophage recruitment in amodiaquine-induced liver injury.
    Mak A; Uetrecht J
    J Immunotoxicol; 2019 Dec; 16(1):28-33. PubMed ID: 30663942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with amodiaquine-modified hepatic proteins prevents amodiaquine-induced liver injury.
    Mak A; Uetrecht J
    J Immunotoxicol; 2015; 12(4):361-7. PubMed ID: 25425471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune mechanisms of idiosyncratic drug-induced liver injury.
    Mak A; Uetrecht J
    J Clin Transl Res; 2017 Feb; 3(1):145-156. PubMed ID: 30873473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid-induced liver injury and immune response in mice.
    Metushi IG; Uetrecht J
    J Immunotoxicol; 2014 Oct; 11(4):383-92. PubMed ID: 24303880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rotenone Increases Isoniazid Toxicity but Does Not Cause Significant Liver Injury: Implications for the Hypothesis that Inhibition of the Mitochondrial Electron Transport Chain Is a Common Mechanism of Idiosyncratic Drug-Induced Liver Injury.
    Cho T; Wang X; Uetrecht J
    Chem Res Toxicol; 2019 Jul; 32(7):1423-1431. PubMed ID: 31251588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring an animal model of amodiaquine-induced liver injury in rats and mice.
    Liu F; Cai P; Metushi I; Li J; Nakayawa T; Vega L; Uetrecht J
    J Immunotoxicol; 2016 Sep; 13(5):694-712. PubMed ID: 27416278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of corticosterone in nevirapine-induced idiosyncratic drug-induced liver injury.
    Jee A; Sernoskie SC; Uetrecht J
    Toxicol Sci; 2024 Jun; 200(1):146-164. PubMed ID: 38636494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supernatant from Hepatocyte Cultures with Drugs That Cause Idiosyncratic Liver Injury Activates Macrophage Inflammasomes.
    Kato R; Uetrecht J
    Chem Res Toxicol; 2017 Jun; 30(6):1327-1332. PubMed ID: 28525267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing Possible Risk Factors for Idiosyncratic Drug-Induced Liver Injury Using an Amodiaquine Mouse Model and Co-treatment with 1-Methyl-d-Tryptophan or Acetaminophen.
    Cho T; Kok LY; Uetrecht J
    ACS Omega; 2021 Feb; 6(7):4656-4662. PubMed ID: 33644572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury.
    Hadi M; Chen Y; Starokozhko V; Merema MT; Groothuis GM
    Chem Res Toxicol; 2012 Sep; 25(9):1938-47. PubMed ID: 22870868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional profiling suggests that Nevirapine and Ritonavir cause drug induced liver injury through distinct mechanisms in primary human hepatocytes.
    Terelius Y; Figler RA; Marukian S; Collado MS; Lawson MJ; Mackey AJ; Manka D; Qualls CW; Blackman BR; Wamhoff BR; Dash A
    Chem Biol Interact; 2016 Aug; 255():31-44. PubMed ID: 26626330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.